|Dr. John F. Regan||Founder, Chairman & CEO||374.84k||N/A||N/A|
|Mr. Darrel M. Rebeck||Co-founder, Pres & Director||305.46k||N/A||N/A|
|Mr. Jeffrey Mitchell||CFO, Treasurer & Corp. Sec.||284.42k||N/A||N/A|
|Mr. Steven Armstrong||VP of Operations||N/A||N/A||N/A|
|Mr. Allan John Fabbro||VP of Corp. Devel.||N/A||N/A||1957|
|Nicole Ridgedale||Director of Corp. Marketing||N/A||N/A||N/A|
|Jay Adelaar||VP of Capital Markets||N/A||N/A||N/A|
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.
LexaGene Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.